Skip to content

Observational Study of Angiographic Coregistered Optical Coherence Tomography in Patients Undergoing PCI

Impact of Angiographic Coregistered Optical Coherence Tomography-diagnostics on Physicians Decision-making During Percutaneous Coronary Intervention in Patients With Advanced Coronary Artery Disease - the OPTICO-Integration-Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02919943
Enrollment
50
Registered
2016-09-30
Start date
2016-07-31
Completion date
2016-09-30
Last updated
2017-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

To define and evaluate the impact of angiographic coregistered OCT on physicians decision-making through prospective data collection in PCI procedures.

Interventions

PROCEDUREPercutaneous Coronary Intervention

OCT-guided Percutaneous Coronary Intervention.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years. * Patient provides signed written informed consent before any study-specific procedure. * Patients suffer from coronary artery disease (CAD) including at least one angiographically significant (\>70% visual estimation) stenosis present in a native coronary artery with planned PCI.

Exclusion criteria

* Subjects with emergent PCI or in cardiogenic shock. * Subjects with target left main (LM) lesion, with restenosis or stent thrombosis in the target vessel or with aorto-ostial lesion location within 3 mm of the aorta junction (both right and left). * Extreme angulation (\> 90°) or excessive tortuosity (\> two 45° angles) proximal to or within the target lesion. * Known renal insufficiency (examples being but not limited to estimated glomerular Filtration rate (eGFR) \< 50 ml/kg/m2, serum creatinine ≥ 2.5 mg/dL or on dialysis). * Any other medical condition that in the opinion of the investigator will interfere with patients safety or study results. * Currently participating in another clinical study that interferes with study results. * Pregnant or nursing subjects and those who plan pregnancy in the period up to 1 year following index procedure. * Any condition that precludes the subject from undergoing PCI, for example subjects with heparin induced thrombocytopenia, or contrast allergy

Design outcomes

Primary

MeasureTime frame
The primary study objective is the change in PCI strategy after pre-procedural ACR as compared to OCT imaging alone20 months

Secondary

MeasureTime frame
Major adverse cardiac event (MACE)-rate (death, myocardial infarction, Re-angiography, Re-PCI and renal failure requiring dialysis), after recruitment.30 days, 6 months, and 12 months.
Change in PCI strategy after pre-procedural OCT imaging in comparison to conventional angiography alone.20 months
Longitudinal geographical miss (GM) with uncovered residual parts of target lesion at the proximal or distal reference segment of the stent. Detected by comparison between pre-PCI OCT with post-PCI OCT.20 months
Rate of side branch occlusions (%).20 months
Strategy changes based on post-procedural OCT and ACR Imaging.20 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026